Medical Brief: PIK3CA and KRAS Mutations Predict for Response to Everolimus Therapy
PIK3CA and KRAS mutations predict for response to everolimus therapy: now that’s RAD001 Morassa Mohseni, Ben Ho Park J Clin Invest. 2010;120(8):2655-2658. https://doi.org/10.1172/JCI44026.
Rising Women in Veterinary Oncology
An introduction from Chief Medical Officer, Dr. Gerry Post Veterinary medicine is changing. I remember one of my first days in veterinary school looking at the class pictures that were hung in the hallways. I remember seeing the first woman in one of these class photos and noting that she was still practicing.
World Veterinary Day Interview: Strengthening Veterinary Resilience
Resilience is defined as the capacity to recover quickly from difficulties and toughness– there are both physical and psychological resilience. Both have been severely tested these last few years with the pandemic, the current war, national divisions, etc. and have really affected veterinarians in the world at large.
Personalized Medicine: Because Not All Tumors Are Created Equally
With new research and medical advancements, immunotherapy is the new frontier in veterinary oncology. Please join us in welcoming Dr. Nicola Mason, B.Vet.Med, PhD, DACVIM (Internal Medicine), Professor of Medicine & Pathobiology at the University of Pennsylvania School of Veterinary Medicine. She is an innovator in veterinary immunology, leading clinical studies and research laboratories investigating […]
Literature Support for Targeted Therapy
In recent academic literature, there have been more and more publications documenting that biochemical pathways in canine cancer cells are often dysregulated, and therefore, targeted therapies are likely of value.
Real World Evidence in Veterinary Medicine: the Golden Retriever Lifetime Study
In veterinary cancer care, it’s common to come across tough clinical questions where there is no known right answer.
Real World Evidence: What is it? From Human Cancer Care to Veterinary Cancer Care
In veterinary cancer care, it’s common to come across tough clinical questions where there is no known right answer. A few examples include:
Mental Health in the Veterinary Community in the Age of COVID-19
Mental health for veterinary professionals can be a challenge in the best of times and even more so during the stressful COVID-19 pandemic. Many of us are concerned with keeping our teams mentally healthy and happily engaged.In the seventh webinar of this series, we welcome Dr. Carrie Jurney, DVM, DACVIM (Neurology), President of Not One […]
Compounding Pharmaceuticals in the Age of COVID-19, Part 2
In our fifth webinar of this series, we welcome Joe Costa, COO of Wedgewood Pharmacy, to discuss the effects of the COVID-19 pandemic on the veterinary compounding pharmaceutical industry. Joe will share how Wedgewood has been able to deliver for veterinarians and their patients despite COVID-19 disruption.
Veterinary Targeted Therapies in the Time of COVID-19, Part 2
In the second segment of our third webinar, Dr. Pamela Schwartz shared experiences from the epicenter of the US COVID-19 crisis: New York City. Dr. Schwartz is the Chair of Department of Surgery, Soft Tissue & Orthopedics at the Animal Medical Center, the largest animal hospital in NY. Leading the surgery department at the largest […]